×
About 11,092 results

ALLMedicine™ Clostridium Difficile Infection Center

Research & Reviews  4,979 results

Do the types and routes of proton pump inhibitor treatments affect Clostridium difficil...
https://doi.org/10.1080/17512433.2021.1890582
Expert Review of Clinical Pharmacology; Lee P, Fike D et. al.

Feb 12th, 2021 - Background: Proton pump inhibitor (PPI) exposure is associated with Clostridium difficile infection (CDI). The impact of the route of administration is unknown. Patients in the Multiparameter Intelligent Monitoring in Intensive Care II database (M...

Risk of acute kidney injury and Clostridioides difficile infection with piperacillin/ta...
https://doi.org/10.1093/cid/ciaa1902
Clinical Infectious Diseases : an Official Publication Of... Lee JD, Heintz BH et. al.

Dec 31st, 2020 - Empiric antimicrobial therapy for healthcare-acquired infections often includes vancomycin plus an antipseudomonal beta-lactam (AP-BL). These agents vary in risk for adverse events, including acute kidney injury (AKI) and Clostridium difficile inf...

Effects of heat-killed Enterococcus faecalis T-110 supplementation on gut immunity, gut...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773277
PloS One; Inatomi T, Otomaru K

Dec 30th, 2020 - Infectious diseases are a threat to elderly individuals, whose immune systems weaken with age. Among the various infectious diseases, Clostridium difficile infection is associated with a high rate of mortality in elderly individuals and is a serio...

Anastomotic Leak is Increased With Clostridium difficile Infection After Colectomy: Mac...
https://doi.org/10.1177/0003134820973720
The American Surgeon; Baker SE, Monlezun DJ et. al.

Dec 28th, 2020 - Clostridium difficile infection (CDI) is now the most common cause of healthcare-associated infections, with increasing prevalence, severity, and mortality of nosocomial and community-acquired CDI which makes up approximately one third of all CDI....

see more →

Guidelines  33 results

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children
https://journals.lww.com/jpgn/Fulltext/2019/01000/Fecal_Microbiota_Transplantation_for_Recurrent.25.aspx
Davidovics,Z.,et al

Jan 21st, 2019 - Fecal microbiota transplantation (FMT) is becoming part of the treatment algorithms against recurrent Clostridium difficile infection (rCDI) both in adult and pediatric gastroenterology practice. With our increasing recognition of the critical rol...

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostr...
https://doi.org/10.1016/j.jhin.2018.07.037
The Journal of Hospital Infection; Mullish BH, Quraishi MN et. al.

Sep 3rd, 2018 - The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.|20...

Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents ...
http://ascopubs.org/doi/full/10.1200/JCO.18.00407
Diorio, C.

Aug 31st, 2018 - The aim of this work was to develop a clinical practice guideline for the prevention and treatment of Clostridium difficile infection (CDI) in children and adolescents with cancer and pediatric hematopoietic stem-cell transplantation (HSCT) patients.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostr...
https://doi.org/10.1136/gutjnl-2018-316818
Gut Mullish BH, Quraishi MN et. al.

Aug 29th, 2018 - Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it has been used as an intervention. The main focus of these studies ...

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium...
https://gut.bmj.com/content/early/2018/08/27/gutjnl-2018-316818
Mullish, B.

Aug 27th, 2018 - Interest in the therapeutic potential of faecal microbiota transplant (FMT) has been increasing globally in recent years, particularly as a result of randomised studies in which it has been used as an intervention. The main focus of these studies.

see more →

Drugs  4 results see all →

Clinicaltrials.gov  5,435 results

Do the types and routes of proton pump inhibitor treatments affect Clostridium difficil...
https://doi.org/10.1080/17512433.2021.1890582
Expert Review of Clinical Pharmacology; Lee P, Fike D et. al.

Feb 12th, 2021 - Background: Proton pump inhibitor (PPI) exposure is associated with Clostridium difficile infection (CDI). The impact of the route of administration is unknown. Patients in the Multiparameter Intelligent Monitoring in Intensive Care II database (M...

Risk of acute kidney injury and Clostridioides difficile infection with piperacillin/ta...
https://doi.org/10.1093/cid/ciaa1902
Clinical Infectious Diseases : an Official Publication Of... Lee JD, Heintz BH et. al.

Dec 31st, 2020 - Empiric antimicrobial therapy for healthcare-acquired infections often includes vancomycin plus an antipseudomonal beta-lactam (AP-BL). These agents vary in risk for adverse events, including acute kidney injury (AKI) and Clostridium difficile inf...

Effects of heat-killed Enterococcus faecalis T-110 supplementation on gut immunity, gut...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773277
PloS One; Inatomi T, Otomaru K

Dec 30th, 2020 - Infectious diseases are a threat to elderly individuals, whose immune systems weaken with age. Among the various infectious diseases, Clostridium difficile infection is associated with a high rate of mortality in elderly individuals and is a serio...

Anastomotic Leak is Increased With Clostridium difficile Infection After Colectomy: Mac...
https://doi.org/10.1177/0003134820973720
The American Surgeon; Baker SE, Monlezun DJ et. al.

Dec 28th, 2020 - Clostridium difficile infection (CDI) is now the most common cause of healthcare-associated infections, with increasing prevalence, severity, and mortality of nosocomial and community-acquired CDI which makes up approximately one third of all CDI....

see more →

News  641 results

Fecal Transplants: 5 Things to Know
https://www.staging.medscape.com/viewarticle/922705

Dec 16th, 2019 - Although fecal microbiota transplantation (FMT) has not yet received approval from the US Food and Drug Administration (FDA), more than 10,000 patients receive FMT in the United States each year to treat Clostridium difficile infection, and hundre...

Probiotic Use for the Prevention of Antibiotic- Associated Clostridium difficile Infection
https://www.mdedge.com/fedprac/article/202170/health-policy/probiotic-use-prevention-antibiotic-associated-clostridium/page/0/1?channel=112

Jun 3rd, 2019 - Review of Probiotoc Literature Conflicting data exist about probiotics and their effect on CDI prevention. The literature reviewed was selected based on our assessment of its contribution to the topic and its potential utility to clinicians in det.

FMT explored as a potential weight loss treatment
https://www.mdedge.com/familymedicine/article/200745/obesity/fmt-explored-potential-weight-loss-treatment?channel=39313
MDedge Endocrinology; Doug Brunk

May 12th, 2019 - Performing fecal microbiota transplantation in medically uncompromised obese individuals did not result in weight loss nor an increase of the gut hormone glucagon-like peptide 1 (GLP-1) at 12 weeks, but it did contribute to a decrease in primary b.

Longer Course of Surgical Abx Tied to More Adverse Events
https://www.medpagetoday.com/infectiousdisease/infectioncontrol/79413

Apr 24th, 2019 - Longer duration of antibiotic prophylaxis after major surgery was associated with higher odds of acute kidney injury (AKI) and higher odds of Clostridium difficile infection, researchers found. There was a duration-dependent relationship between o...

Jury Still Out on Fecal Transplants for Obesity
https://www.staging.medscape.com/viewarticle/908735

Feb 5th, 2019 - Could fecal microbiota transplantation (FMT), whereby medical-processed stool material from a healthy donor is introduced into the intestine of a patient with obesity, be one of the answers to tackling this disease? That is the belief of several g...

see more →